University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved, the ...
especially because alendronate is incorporated in bone matrix and has a biological half-life of more than 10 years. In this study, a total of 1099 postmenopausal women (mean age, 73 ...